MCM
JAZZ icon

McKinley Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

McKinley Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,700
Closed -$286K – 298
2018
Q3 		$286K Sell
1,700
-8
-0.5% -$1.38K 0.02% 179
2018
Q2 		$295K Buy
1,708
+909
+114% +$149K 0.02% 192
2018
Q1 		$120K Buy
799
+322
+68% +$47.2K 0.01% 251
2017
Q4 		$64K Sell
477
-331
-41% -$45.9K ﹤0.01% 319
2017
Q3 		$118K Sell
808
-24
-3% -$3.63K ﹤0.01% 312
2017
Q2 		$129K Sell
832
-15
-2% -$2.29K ﹤0.01% 319
2017
Q1 		$123K Sell
847
-49
-5% -$6.38K ﹤0.01% 382
2016
Q4 		$98K Sell
896
-1,066
-54% -$119K ﹤0.01% 385
2016
Q3 		$238K Sell
1,962
-10
-0.5% -$1.35K 0.01% 346
2016
Q2 		$279K Sell
1,972
-75
-4% -$11.1K 0.01% 300
2016
Q1 		$267K Sell
2,047
-185
-8% -$23K 0.01% 283
2015
Q4 		$314K Buy
2,232
+7
+0.3% +$970 0.01% 278
2015
Q3 		$296K Sell
2,225
-126
-5% -$21.7K 0.01% 285
2015
Q2 		$414K Sell
2,351
-94,699
-98% -$17M 0.02% 272
2015
Q1 		$16.8M Sell
97,050
-1,641
-2% -$282K 0.67% 42
2014
Q4 		$16.2M Sell
98,691
-2,122
-2% -$352K 0.65% 45
2014
Q3 		$16.2M Sell
100,813
-2,790
-3% -$429K 0.71% 42
2014
Q2 		$15.2M Sell
103,603
-5,797
-5% -$804K 0.62% 48
2014
Q1 		$15.2M Sell
109,400
-11,214
-9% -$1.69M 0.64% 44
2013
Q4 		$15.3M Sell
120,614
-5,159
-4% -$534K 0.6% 44
2013
Q3 		$11.6M Buy
125,773
+116,517
+1,259% +$9.4M 0.51% 54
2013
Q2 		$636K Buy
+9,256
New +$566K 0.03% 233

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

McKinley Capital Management's JAZZ Position: Q4 2018 in Review

McKinley Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2018, closing a stake of 1,700 shares — an estimated $286K sold.

McKinley Capital Management first reported a position in JAZZ in Q2 2013 and held it in 22 quarters. The position peaked at $16.8M in Q1 2015. 417 funds tracked by Wall St. Rank hold JAZZ as of Q4 2018.

  • McKinley Capital Management reported no remaining Jazz Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • McKinley Capital Management sold 1,700 Jazz Pharmaceuticals shares in Q4 2018, an estimated $286K.
  • McKinley Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • McKinley Capital Management's Jazz Pharmaceuticals position peaked at $16.8M in Q1 2015.
  • 417 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2018.

Based on McKinley Capital Management's 13F filing for Q4 2018, filed 11 Feb 2019.